<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <title>LiquidMammo™ | Breast cancer screening, reimagined</title>

  <!-- SEO -->
  <meta name="description" content="LiquidMammo is a microRNA-based blood test designed to complement imaging for earlier breast cancer detection—non-invasive, clinician-ordered, and density-aware.">
  <meta name="keywords" content="breast cancer screening, microRNA test, liquid biopsy, early detection, dense breasts, molecular diagnostics">

  <!-- Stylesheet -->
  <link rel="stylesheet" href="assets/css/styles.css" />

  <!-- Favicon -->
  <link rel="icon" href="favicon.png" type="image/png" />
</head>

<body>

<!-- ======================================
     HEADER
======================================= -->
<header>
  <div class="container">
    <nav>

      <!-- Brand -->
      <div class="brand">
        <img src="assets/logos/liquidmammo-logo.png" alt="LiquidMammo logo" />
        <strong>LiquidMammo™</strong>
      </div>

      <!-- Navigation -->
      <div class="nav-links">
        <a href="how-it-works.html">How It Works</a>
        <a href="science.html">Science</a>
        <a href="evidence.html">Evidence</a>
        <a href="patients.html">Patients</a>
        <a href="clinicians.html">Clinicians</a>
        <a href="biobank.html">Biobank</a>
        <a href="pricing.html">Pricing</a>
        <a href="contact.html">Contact</a>
        <a href="privacy.html">Privacy</a>
        <a href="about.html">About</a>
      </div>

    </nav>
  </div>
</header>


<!-- ======================================
     HERO (TEXT-ONLY — logo is only in header)
======================================= -->
<section class="hero">
  <div class="container" style="text-align:center;">

    <h1 style="font-size:2.4rem; margin-bottom:10px;">
      Breast cancer screening, reimagined.
    </h1>

    <p class="kicker" style="font-size:1rem; margin-bottom:20px;">
      A microRNA blood test designed to complement imaging.
    </p>

    <p class="small" style="max-width:650px; margin:0 auto 24px auto;">
      Early molecular changes often precede structural findings on mammography.
      LiquidMammo provides a non‑invasive signal that strengthens clinical
      decision‑making—especially where breast density limits traditional
      imaging performance.
    </p>

    <div class="cta-row" style="justify-content:center;">
      <a class="btn" href="patients.html#patients">Join Early Access</a>
      <a class="btn secondary" href="clinicians.html#enroll">Clinician Enrollment</a>
    </div>

    <p class="notice" style="max-width:600px; margin:24px auto 0 auto;">
      Regulatory: LiquidMammo is being developed as a
      <strong>CLIA Laboratory Developed Test (LDT)</strong>;
      not yet FDA‑cleared or FDA‑approved.
    </p>

  </div>
</section>


<!-- ======================================
     WHY IT MATTERS
======================================= -->
<section class="panel-light section">
  <div class="container grid-3">

    <div class="card-mini">
      <h4>Dense breasts challenge mammography</h4>
      <p class="small">
        Sensitivity drops to ~61% in extremely dense tissue. A molecular complement may reduce misses.
      </p>
    </div>

    <div class="card-mini">
      <h4>Earlier biological signal</h4>
      <p class="small">
        microRNA shifts can occur before imaging-visible lesions, strengthening screening performance.
      </p>
    </div>

    <div class="card-mini">
      <h4>Addresses real‑world variability</h4>
      <p class="small">
        Mammographic detection varies by density, age, and equipment. A molecular layer improves consistency.
      </p>
    </div>

  </div>
</section>


<!-- ======================================
     CLINICAL CONTEXT
======================================= -->
<section class="section">
  <div class="container">

    <h2>Clinical context</h2>

    <div class="grid-3">

      <div class="stats-card">
        <ul class="list-tight">
          <li><strong>1 in 8</strong> cancers missed by mammography overall</li>
          <li><strong>Higher interval cancer rates</strong> in dense breasts</li>
          <li><strong>~50–60%</strong> false‑positive probability over 10 years</li>
        </ul>
      </div>

      <div class="stats-card">
        <ul class="list-tight">
          <li><strong>~61% sensitivity</strong> in extremely dense tissue</li>
          <li><strong>2–3 per 1,000</strong> cancers detected in younger women</li>
          <li><strong>Lower participation</strong> when imaging alone is used</li>
        </ul>
      </div>

      <div class="card note-card">
        <p class="small">
          LiquidMammo complements—rather than replaces—imaging. Combining biology + imaging improves consistency.
        </p>
      </div>

    </div>

  </div>
</section>


<!-- ======================================
     HOW IT WORKS
======================================= -->
<section class="panel-light section">
  <div class="container">
    <h2>How it works</h2>

    <div class="grid-3">

      <div class="card-mini">
        <h4>1 — Ordered by clinician</h4>
        <p class="small">Blood draw at routine visit; no preparation needed.</p>
      </div>

      <div class="card-mini">
        <h4>2 — microRNA profiling</h4>
        <p class="small">A multi‑marker panel quantifies tumor‑associated microRNA dysregulation.</p>
      </div>

      <div class="card-mini">
        <h4>3 — Clinician‑ready report</h4>
        <p class="small">Delivered with density‑aware interpretation and subgroup context.</p>
      </div>

    </div>
  </div>
</section>


<!-- ======================================
     FOOTER
======================================= -->
<footer>
  <div class="container footer-grid">

    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC,
        and operates out of LabCentral, Cambridge, MA.
      </p>
    </div>

    <div class="footer-logo">
      <img src="assets/logos/multiomics-logo.png" alt="MultiOmics logo" />
      <div class="footer-note" style="line-height:1.2">
        Developed by<br/>MultiOmics Inc.
      </div>
    </div>

  </div>

  <div class="container footer-note
